Global Osteoarthritis Gene Therapy Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 31 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Osteoarthritis Gene Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Osteoarthritis Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Osteoarthritis Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Osteoarthritis Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Osteoarthritis Gene Therapy total market, 2018-2029, (USD Million)
Global Osteoarthritis Gene Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Osteoarthritis Gene Therapy total market, key domestic companies and share, (USD Million)
Global Osteoarthritis Gene Therapy revenue by player and market share 2018-2023, (USD Million)
Global Osteoarthritis Gene Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Osteoarthritis Gene Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Osteoarthritis Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Flexion, GeneQuine, Novartis, Smith & Nephew, Genascence, Kolon TissueGene, Sanofi, Paraxel and Medipost, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Osteoarthritis Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Osteoarthritis Gene Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Osteoarthritis Gene Therapy Market, Segmentation by Type
    Synovium Injection
    Cartilage Injection

Global Osteoarthritis Gene Therapy Market, Segmentation by Application
    Hospitals and clinics
    Orthopedic Centers
    Assisted living Facilities
    Nursing Homes
    Ambulatory Surgical Centers
    Others

Companies Profiled:
    Flexion
    GeneQuine
    Novartis
    Smith & Nephew
    Genascence
    Kolon TissueGene
    Sanofi
    Paraxel
    Medipost
    Mundipharma

Key Questions Answered
1. How big is the global Osteoarthritis Gene Therapy market?
2. What is the demand of the global Osteoarthritis Gene Therapy market?
3. What is the year over year growth of the global Osteoarthritis Gene Therapy market?
4. What is the total value of the global Osteoarthritis Gene Therapy market?
5. Who are the major players in the global Osteoarthritis Gene Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Osteoarthritis Gene Therapy Introduction
    1.2 World Osteoarthritis Gene Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Osteoarthritis Gene Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Osteoarthritis Gene Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Osteoarthritis Gene Therapy Market Size (2018-2029)
        1.3.3 China Osteoarthritis Gene Therapy Market Size (2018-2029)
        1.3.4 Europe Osteoarthritis Gene Therapy Market Size (2018-2029)
        1.3.5 Japan Osteoarthritis Gene Therapy Market Size (2018-2029)
        1.3.6 South Korea Osteoarthritis Gene Therapy Market Size (2018-2029)
        1.3.7 ASEAN Osteoarthritis Gene Therapy Market Size (2018-2029)
        1.3.8 India Osteoarthritis Gene Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Osteoarthritis Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Osteoarthritis Gene Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.2 World Osteoarthritis Gene Therapy Consumption Value by Region
        2.2.1 World Osteoarthritis Gene Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Osteoarthritis Gene Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.4 China Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.5 Europe Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.6 Japan Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.7 South Korea Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.8 ASEAN Osteoarthritis Gene Therapy Consumption Value (2018-2029)
    2.9 India Osteoarthritis Gene Therapy Consumption Value (2018-2029)

3 World Osteoarthritis Gene Therapy Companies Competitive Analysis
    3.1 World Osteoarthritis Gene Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Osteoarthritis Gene Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Osteoarthritis Gene Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Osteoarthritis Gene Therapy in 2022
    3.3 Osteoarthritis Gene Therapy Company Evaluation Quadrant
    3.4 Osteoarthritis Gene Therapy Market: Overall Company Footprint Analysis
        3.4.1 Osteoarthritis Gene Therapy Market: Region Footprint
        3.4.2 Osteoarthritis Gene Therapy Market: Company Product Type Footprint
        3.4.3 Osteoarthritis Gene Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Osteoarthritis Gene Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Osteoarthritis Gene Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Osteoarthritis Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Osteoarthritis Gene Therapy Consumption Value Comparison
        4.2.1 United States VS China: Osteoarthritis Gene Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Osteoarthritis Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Osteoarthritis Gene Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Osteoarthritis Gene Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Osteoarthritis Gene Therapy Revenue, (2018-2023)
    4.4 China Based Companies Osteoarthritis Gene Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Osteoarthritis Gene Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Osteoarthritis Gene Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Osteoarthritis Gene Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Osteoarthritis Gene Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Osteoarthritis Gene Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Osteoarthritis Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Synovium Injection
        5.2.2 Cartilage Injection
    5.3 Market Segment by Type
        5.3.1 World Osteoarthritis Gene Therapy Market Size by Type (2018-2023)
        5.3.2 World Osteoarthritis Gene Therapy Market Size by Type (2024-2029)
        5.3.3 World Osteoarthritis Gene Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Osteoarthritis Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and clinics
        6.2.2 Orthopedic Centers
        6.2.3 Assisted living Facilities
        6.2.4 Nursing Homes
        6.2.5 Nursing Homes
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Osteoarthritis Gene Therapy Market Size by Application (2018-2023)
        6.3.2 World Osteoarthritis Gene Therapy Market Size by Application (2024-2029)
        6.3.3 World Osteoarthritis Gene Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Flexion
        7.1.1 Flexion Details
        7.1.2 Flexion Major Business
        7.1.3 Flexion Osteoarthritis Gene Therapy Product and Services
        7.1.4 Flexion Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Flexion Recent Developments/Updates
        7.1.6 Flexion Competitive Strengths & Weaknesses
    7.2 GeneQuine
        7.2.1 GeneQuine Details
        7.2.2 GeneQuine Major Business
        7.2.3 GeneQuine Osteoarthritis Gene Therapy Product and Services
        7.2.4 GeneQuine Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 GeneQuine Recent Developments/Updates
        7.2.6 GeneQuine Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Osteoarthritis Gene Therapy Product and Services
        7.3.4 Novartis Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Smith & Nephew
        7.4.1 Smith & Nephew Details
        7.4.2 Smith & Nephew Major Business
        7.4.3 Smith & Nephew Osteoarthritis Gene Therapy Product and Services
        7.4.4 Smith & Nephew Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Smith & Nephew Recent Developments/Updates
        7.4.6 Smith & Nephew Competitive Strengths & Weaknesses
    7.5 Genascence
        7.5.1 Genascence Details
        7.5.2 Genascence Major Business
        7.5.3 Genascence Osteoarthritis Gene Therapy Product and Services
        7.5.4 Genascence Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Genascence Recent Developments/Updates
        7.5.6 Genascence Competitive Strengths & Weaknesses
    7.6 Kolon TissueGene
        7.6.1 Kolon TissueGene Details
        7.6.2 Kolon TissueGene Major Business
        7.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Product and Services
        7.6.4 Kolon TissueGene Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Kolon TissueGene Recent Developments/Updates
        7.6.6 Kolon TissueGene Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Osteoarthritis Gene Therapy Product and Services
        7.7.4 Sanofi Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 Paraxel
        7.8.1 Paraxel Details
        7.8.2 Paraxel Major Business
        7.8.3 Paraxel Osteoarthritis Gene Therapy Product and Services
        7.8.4 Paraxel Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Paraxel Recent Developments/Updates
        7.8.6 Paraxel Competitive Strengths & Weaknesses
    7.9 Medipost
        7.9.1 Medipost Details
        7.9.2 Medipost Major Business
        7.9.3 Medipost Osteoarthritis Gene Therapy Product and Services
        7.9.4 Medipost Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Medipost Recent Developments/Updates
        7.9.6 Medipost Competitive Strengths & Weaknesses
    7.10 Mundipharma
        7.10.1 Mundipharma Details
        7.10.2 Mundipharma Major Business
        7.10.3 Mundipharma Osteoarthritis Gene Therapy Product and Services
        7.10.4 Mundipharma Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Mundipharma Recent Developments/Updates
        7.10.6 Mundipharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Osteoarthritis Gene Therapy Industry Chain
    8.2 Osteoarthritis Gene Therapy Upstream Analysis
    8.3 Osteoarthritis Gene Therapy Midstream Analysis
    8.4 Osteoarthritis Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Osteoarthritis Gene Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Osteoarthritis Gene Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Osteoarthritis Gene Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Osteoarthritis Gene Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Osteoarthritis Gene Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Osteoarthritis Gene Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Osteoarthritis Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Osteoarthritis Gene Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Osteoarthritis Gene Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Osteoarthritis Gene Therapy Players in 2022
    Table 12. World Osteoarthritis Gene Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Osteoarthritis Gene Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Osteoarthritis Gene Therapy Player
    Table 15. Osteoarthritis Gene Therapy Market: Company Product Type Footprint
    Table 16. Osteoarthritis Gene Therapy Market: Company Product Application Footprint
    Table 17. Osteoarthritis Gene Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Osteoarthritis Gene Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Osteoarthritis Gene Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Osteoarthritis Gene Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Osteoarthritis Gene Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Osteoarthritis Gene Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Osteoarthritis Gene Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Osteoarthritis Gene Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Osteoarthritis Gene Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Osteoarthritis Gene Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Osteoarthritis Gene Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Osteoarthritis Gene Therapy Revenue Market Share (2018-2023)
    Table 29. World Osteoarthritis Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Osteoarthritis Gene Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Osteoarthritis Gene Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Osteoarthritis Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Osteoarthritis Gene Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Osteoarthritis Gene Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Flexion Basic Information, Area Served and Competitors
    Table 36. Flexion Major Business
    Table 37. Flexion Osteoarthritis Gene Therapy Product and Services
    Table 38. Flexion Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Flexion Recent Developments/Updates
    Table 40. Flexion Competitive Strengths & Weaknesses
    Table 41. GeneQuine Basic Information, Area Served and Competitors
    Table 42. GeneQuine Major Business
    Table 43. GeneQuine Osteoarthritis Gene Therapy Product and Services
    Table 44. GeneQuine Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. GeneQuine Recent Developments/Updates
    Table 46. GeneQuine Competitive Strengths & Weaknesses
    Table 47. Novartis Basic Information, Area Served and Competitors
    Table 48. Novartis Major Business
    Table 49. Novartis Osteoarthritis Gene Therapy Product and Services
    Table 50. Novartis Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Novartis Recent Developments/Updates
    Table 52. Novartis Competitive Strengths & Weaknesses
    Table 53. Smith & Nephew Basic Information, Area Served and Competitors
    Table 54. Smith & Nephew Major Business
    Table 55. Smith & Nephew Osteoarthritis Gene Therapy Product and Services
    Table 56. Smith & Nephew Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Smith & Nephew Recent Developments/Updates
    Table 58. Smith & Nephew Competitive Strengths & Weaknesses
    Table 59. Genascence Basic Information, Area Served and Competitors
    Table 60. Genascence Major Business
    Table 61. Genascence Osteoarthritis Gene Therapy Product and Services
    Table 62. Genascence Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Genascence Recent Developments/Updates
    Table 64. Genascence Competitive Strengths & Weaknesses
    Table 65. Kolon TissueGene Basic Information, Area Served and Competitors
    Table 66. Kolon TissueGene Major Business
    Table 67. Kolon TissueGene Osteoarthritis Gene Therapy Product and Services
    Table 68. Kolon TissueGene Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Kolon TissueGene Recent Developments/Updates
    Table 70. Kolon TissueGene Competitive Strengths & Weaknesses
    Table 71. Sanofi Basic Information, Area Served and Competitors
    Table 72. Sanofi Major Business
    Table 73. Sanofi Osteoarthritis Gene Therapy Product and Services
    Table 74. Sanofi Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Sanofi Recent Developments/Updates
    Table 76. Sanofi Competitive Strengths & Weaknesses
    Table 77. Paraxel Basic Information, Area Served and Competitors
    Table 78. Paraxel Major Business
    Table 79. Paraxel Osteoarthritis Gene Therapy Product and Services
    Table 80. Paraxel Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Paraxel Recent Developments/Updates
    Table 82. Paraxel Competitive Strengths & Weaknesses
    Table 83. Medipost Basic Information, Area Served and Competitors
    Table 84. Medipost Major Business
    Table 85. Medipost Osteoarthritis Gene Therapy Product and Services
    Table 86. Medipost Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Medipost Recent Developments/Updates
    Table 88. Mundipharma Basic Information, Area Served and Competitors
    Table 89. Mundipharma Major Business
    Table 90. Mundipharma Osteoarthritis Gene Therapy Product and Services
    Table 91. Mundipharma Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Osteoarthritis Gene Therapy Upstream (Raw Materials)
    Table 93. Osteoarthritis Gene Therapy Typical Customers
List of Figure
    Figure 1. Osteoarthritis Gene Therapy Picture
    Figure 2. World Osteoarthritis Gene Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Osteoarthritis Gene Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Osteoarthritis Gene Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Osteoarthritis Gene Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Osteoarthritis Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Osteoarthritis Gene Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Osteoarthritis Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Osteoarthritis Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Osteoarthritis Gene Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Osteoarthritis Gene Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Osteoarthritis Gene Therapy Markets in 2022
    Figure 27. United States VS China: Osteoarthritis Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Osteoarthritis Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Osteoarthritis Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Osteoarthritis Gene Therapy Market Size Market Share by Type in 2022
    Figure 31. Synovium Injection
    Figure 32. Cartilage Injection
    Figure 33. World Osteoarthritis Gene Therapy Market Size Market Share by Type (2018-2029)
    Figure 34. World Osteoarthritis Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Osteoarthritis Gene Therapy Market Size Market Share by Application in 2022
    Figure 36. Hospitals and clinics
    Figure 37. Orthopedic Centers
    Figure 38. Assisted living Facilities
    Figure 39. Nursing Homes
    Figure 40. Ambulatory Surgical Centers
    Figure 41. Others
    Figure 42. Osteoarthritis Gene Therapy Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma

Related Reports

Global Osteoarthritis Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Osteoarthritis Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date Medical Care

According to our (Global Info Research) latest study, the global Osteoarthritis Gene Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Osteoarthritis Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Osteoarthritis Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Osteoarthritis Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Osteoarthritis Gene Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>